Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Spartha Medical |
| Country | France |
| Start Date | Aug 01, 2022 |
| End Date | Jul 31, 2025 |
| Duration | 1,095 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190184905 |
Infections represent one of the major risks of surgery implants and the main cause of implant rejection, affecting over 5% of patients who undergo an implant surgery (around 2M patients in the EU).
At SPARTHA Medical, created in 2019 as a spin-off of INSERM Biomaterials Unit (Strasbourg), we developed a multifunctional coating with antimicrobial and anti-inflammatory properties to prevent infections in implants and surgical care.
In addition to this medical coating to be used directly in hospitals, we developed a second product a biocompatible, eco-friendly spray with antibacterial & antiviral properties for general and daily use.
We also offer a customized coating development service for medical device manufacturers which leads to recurring licensing. Our coating platform is so versatile the applications are endless. We are also integrating the development service to electronics and cosmetics companies. We have signed 7 contract agreements so far, and 2 more in advanced negotiations.
Spartha Medical
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant